Usually used to lower blood sugar levels in individuals with type-2 diabetes, Ozempic is back on the lips of medical experts ...

Even if the patient makes a full recovery, a cancer diagnosis could seriously harm their finances, new research has proven.

Discover the latest research on Ozempic and other GLP-1 medications, including potential uses in treating Alzheimer's and opioid and alcohol use disorders.

Alzheimer’s causes a gradual decline in memory, thinking, behaviour, and social skills, and it is the most common cause of ...

Ozempic has quickly become a household name with medical researchers claiming the breakthrough drug can have many benefits.

Global stock markets diverged Friday in an end to a week's trading dominated by earnings updates and angst over rising bond ...

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 ...

Research suggests Ozempic could reduce Alzheimer's risk in type 2 diabetes, with a 67% lower diagnosis rate compared to ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...

The University of Cincinnati's Alberto Espay, MD, commented to NBC News on new research published Oct. 24 that found ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Semaglutide, the active ingredient in Ozempic and Wegovy, may lower the risk of Alzheimer’s disease.A new study suggests type 2 diabetes patients taking semaglu ...